SPATA2/CYLD Pathway-Dependent Deubiquitylation of p53 Promotes Ferroptosis in Rat Heart After Ischaemia/Reperfusion Through Suppression of SLC7A11

  • 0Department of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China; Hunan Provincial Key Laboratory of Cardiovascular Research, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China; Department of Pharmacy, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.

|

|

Summary

This summary is machine-generated.

The SPATA2/CYLD pathway promotes heart cell death (ferroptosis) after ischemia/reperfusion injury by de-ubiquitylating p53, which suppresses SLC7A11 and glutathione peroxidase 4 (GPX4). This pathway exacerbates myocardial I/R injury.

Area Of Science

  • Cardiovascular Biology
  • Cell Death Mechanisms
  • Molecular Pathology

Background

  • Ferroptosis, an iron-dependent cell death, significantly contributes to myocardial ischemia/reperfusion (I/R) injury.
  • Glutathione peroxidase 4 (GPX4) downregulation accelerates ferroptosis, but the precise mechanisms remain unclear.
  • Solute carrier family 7A member 11 (SLC7A11) is crucial for GPX4 levels and its transcription is negatively regulated by p53.

Purpose Of The Study

  • To investigate the role of the spermatogenesis-associated protein 2 (SPATA2)/cylindromatosis (CYLD) pathway in promoting myocardial ferroptosis following I/R.
  • To determine if this pathway acts via p53-dependent inhibition of SLC7A11.

Main Methods

  • Established rat myocardial I/R injury model (1h ischemia, 3h reperfusion).
  • Utilized H9c2 cell model (8h hypoxia, 12h re-oxygenation) to mimic I/R injury in vitro.
  • Assessed protein levels, ubiquitination, and interactions, including SPATA2 knockdown and lurasidone treatment.

Main Results

  • SPATA2 and CYLD levels increased in I/R hearts and H/R cells, correlating with elevated p53.
  • SPATA2 knockdown reversed p53 ubiquitination and levels, increasing SLC7A11 and GPX4, thereby reducing ferroptosis.
  • Lurasidone, an SPATA2 inhibitor, replicated these protective effects in I/R rat hearts.

Conclusions

  • The SPATA2/CYLD pathway promotes ferroptosis in myocardial I/R injury.
  • This occurs through de-ubiquitylation of p53, leading to suppressed SLC7A11 expression.
  • Targeting the SPATA2/CYLD pathway may offer a therapeutic strategy for I/R injury.

Related Concept Videos

Necrosis 01:16

3.8K

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...

Abnormal Proliferation 02:23

4.4K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Covalently Linked Protein Regulators 02:04

6.7K

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....

Regulation of the Unfolded Protein Response 01:31

2.4K

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...

The Unfolded Protein Response 01:37

4.3K

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...

DNA Damage can Stall the Cell Cycle 02:37

9.0K

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...